E.D. Bateman

1.5k total citations
41 papers, 1.1k citations indexed

About

E.D. Bateman is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, E.D. Bateman has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 5 papers in Surgery. Recurrent topics in E.D. Bateman's work include Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). E.D. Bateman is often cited by papers focused on Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). E.D. Bateman collaborates with scholars based in South Africa, United States and Netherlands. E.D. Bateman's co-authors include Edith M. Peters, M Turner‐Warwick, B C Adelmann-Grill, Bo Lundbäck, P L Haslam, Dirk Bredenbröker, Geoffrey J. Laurent, Jose Carrillo, M Britton and J. Almeida and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Thorax.

In The Last Decade

E.D. Bateman

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.D. Bateman South Africa 16 563 474 211 104 102 41 1.1k
B. Wiedemann Germany 22 705 1.3× 87 0.2× 23 0.1× 109 1.0× 69 0.7× 41 1.3k
M Topilsky Israel 21 605 1.1× 503 1.1× 16 0.1× 100 1.0× 15 0.1× 94 1.3k
Shmuel Kivity Israel 23 483 0.9× 488 1.0× 19 0.1× 89 0.9× 17 0.2× 73 1.7k
Vesa Koivukangas Finland 20 388 0.7× 66 0.1× 90 0.4× 37 0.4× 40 0.4× 71 1.1k
A. Seekamp Germany 23 156 0.3× 115 0.2× 81 0.4× 99 1.0× 23 0.2× 92 1.7k
David Casal United States 22 380 0.7× 134 0.3× 66 0.3× 747 7.2× 136 1.3× 33 2.0k
Henning Onarheim Norway 15 97 0.2× 43 0.1× 137 0.6× 111 1.1× 73 0.7× 39 732
Christoph Trautner Germany 14 135 0.2× 215 0.5× 190 0.9× 95 0.9× 3 0.0× 19 1.1k
Aleah L. Brubaker United States 12 144 0.3× 101 0.2× 99 0.5× 47 0.5× 18 0.2× 33 754
J. L. Berry United Kingdom 18 50 0.1× 118 0.2× 32 0.2× 134 1.3× 88 0.9× 34 1.2k

Countries citing papers authored by E.D. Bateman

Since Specialization
Citations

This map shows the geographic impact of E.D. Bateman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.D. Bateman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.D. Bateman more than expected).

Fields of papers citing papers by E.D. Bateman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.D. Bateman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.D. Bateman. The network helps show where E.D. Bateman may publish in the future.

Co-authorship network of co-authors of E.D. Bateman

This figure shows the co-authorship network connecting the top 25 collaborators of E.D. Bateman. A scholar is included among the top collaborators of E.D. Bateman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.D. Bateman. E.D. Bateman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taborda‐Barata, Luís, Greg Calligaro, Richard N. van Zyl-Smit, et al.. (2018). Five-year follow-up of participants diagnosed with chronic airflow obstruction in a South African Burden of Obstructive Lung Disease (BOLD) survey. South African Medical Journal. 108(2). 138–138. 2 indexed citations
3.
Meltzer, Eli O., Paul Chervinsky, William W. Busse, et al.. (2015). Roflumilast for asthma: Efficacy findings in placebo-controlled studies. Pulmonary Pharmacology & Therapeutics. 35. S20–S27. 31 indexed citations
4.
Koegelenberg, Coenraad F.N., et al.. (2014). Efficacy of Varenicline Combined With Nicotine Replacement Therapy vs Varenicline Alone for Smoking Cessation: A Randomized Clinical Trial. Journal of Vascular Surgery. 60(4). 1096–1096. 15 indexed citations
5.
Dawson, Rodney, William N. Rom, Keertan Dheda, & E.D. Bateman. (2013). The new epidemic of non-communicable disease in people living with the human immunodeficiency virus [Perspective]. Public Health Action. 3(1). 4–6. 4 indexed citations
6.
Casale, Thomas B., ER Bleecker, E Meltzer, et al.. (2013). Phase III trials to investigate tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: trial design and planned statistical analyses. Data Archiving and Networked Services (DANS). 68. 377–377. 4 indexed citations
7.
Baatjies, Roslynn, Andreas L. Lopata, Ingrid Sander, et al.. (2009). Determinants of asthma phenotypes in supermarket bakery workers. European Respiratory Journal. 34(4). 825–833. 42 indexed citations
8.
Feldman, Charles, Adrian Brink, Guy A. Richards, Gary Maartens, & E.D. Bateman. (2008). Management of community-acquired pneumonia in adults. Southern African Journal of Epidemiology and Infection. 23(2). 31–42. 27 indexed citations
9.
Bateman, E.D., et al.. (2006). Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Respiratory Research. 7(1). 13–13. 39 indexed citations
10.
Bateman, E.D., et al.. (2006). Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: A pilot study. Pulmonary Pharmacology & Therapeutics. 21(1). 20–25. 25 indexed citations
11.
Obihara, Charlie C., Robert P. Gie, P. Potter, et al.. (2005). The association of prolonged breastfeeding and allergic disease in poor urban children. European Respiratory Journal. 25(6). 970–977. 51 indexed citations
12.
Bethke, T.D., et al.. (2004). Long-term Safety of Roflumilast in the Treatment of Chronic Obstructive Pulmonary Disease. CHEST Journal. 126(4). 805S–805S. 1 indexed citations
13.
Rabe, Klaus F., et al.. (2004). Roflumilast Improves Lung Function and Quality of Life in Chronic Obstructive Pulmonary Disease. CHEST Journal. 126(4). 709S–709S. 4 indexed citations
14.
Bateman, E.D., et al.. (1998). Salmeterol/Fluticasone Combination Inhaler. Clinical Drug Investigation. 16(3). 193–201. 65 indexed citations
15.
Bateman, E.D. & Stuart C. Morrison. (1990). Catamenial haemoptysis from endobronchial endometriosis—A case report and review of previously reported cases. Respiratory Medicine. 84(2). 157–161. 13 indexed citations
16.
Willcox, Paul A., E.D. Bateman, Peter D. Potgieter, & Solomon R. Benatar. (1990). Experience with fibreoptic bronchoscopy in the diagnosis of pulmonary shadows in renal transplant recipients over a 12-year period. Respiratory Medicine. 84(4). 297–302. 7 indexed citations
17.
Bateman, E.D., et al.. (1990). Prognostic and therapeutic considerations in clinicalprimary pulmonary hypertension. Respiratory Medicine. 84(6). 489–494. 12 indexed citations
18.
Bateman, E.D., et al.. (1990). Primary pulmonary hypertension and thromboembolicpulmonary hypertension—similarities and differences. Respiratory Medicine. 84(6). 485–488. 9 indexed citations
19.
Bateman, E.D., M Turner‐Warwick, P L Haslam, & B C Adelmann-Grill. (1983). Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens.. Thorax. 38(2). 93–101. 37 indexed citations
20.
Peters, Edith M. & E.D. Bateman. (1983). Ultramarathon running and upper respiratory tract infections. An epidemiological survey.. PubMed. 64(15). 582–4. 252 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026